| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.72B | 27.60B | 35.62B | 30.93B | 22.51B | 27.32B |
| Gross Profit | 8.65B | 9.18B | 7.77B | 5.75B | 4.74B | 6.21B |
| EBITDA | 9.24B | 9.74B | 8.43B | 7.01B | 5.93B | 7.01B |
| Net Income | 1.74B | 3.55B | 1.23B | -2.23B | 857.70M | 2.42B |
Balance Sheet | ||||||
| Total Assets | 71.82B | 71.98B | 72.78B | 74.84B | 84.05B | 78.71B |
| Cash, Cash Equivalents and Short-Term Investments | 21.54B | 20.70B | 21.21B | 16.58B | 16.98B | 26.87B |
| Total Debt | 20.87B | 17.96B | 21.36B | 25.37B | 33.22B | 28.05B |
| Total Liabilities | 28.75B | 26.82B | 30.51B | 34.52B | 42.38B | 38.51B |
| Stockholders Equity | 36.84B | 37.78B | 36.24B | 35.18B | 37.55B | 36.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.17B | 6.47B | 7.34B | -14.25B | 11.38B |
| Operating Cash Flow | 0.00 | 7.90B | 15.43B | 10.90B | -12.45B | 13.16B |
| Investing Cash Flow | 0.00 | -1.33B | -6.72B | -3.38B | -2.54B | -2.44B |
| Financing Cash Flow | 0.00 | -5.55B | -4.27B | -7.93B | 4.91B | -5.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥34.17B | 15.79 | ― | 3.63% | 1.04% | 26.51% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥248.33B | 12.92 | ― | 1.51% | ― | ― | |
59 Neutral | ¥30.34B | 8.74 | ― | 0.93% | -22.53% | 196.56% | |
53 Neutral | ¥91.67B | 18.63 | ― | ― | 52.78% | -7.69% | |
51 Neutral | ¥49.79B | 17.63 | ― | ― | 6.93% | ― | |
48 Neutral | ¥63.69B | -8.97 | -78.01% | ― | 4.03% | -747.77% |